Our results suggest that the cell-type specific depleted signals in cancer cell lines may be under genomic alterations and can be located near genes associated with different types of cancer (i.e. FHIT, STK11, CDKN2A, CDKN2B). This evidence concerns the gene CDKN2B and cancer.